Harrison, LH, et al.
The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine
2011; 29: 3363–3371.
John, TJ, et al.
An overview of meningococcal disease in India: knowledge gaps and potential solutions. Vaccine
2013; 31: 2731–2737.
Sáfadi, MA, et al.
The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative. Expert Review of Vaccines
2013; 12: 903–915.
Borrow, R, et al.
Safe laboratory handling of Neisseria meningitidis
. Journal of Infection
2014; 68: 305–312.
Olcen, P, Fredlund, H. Isolation, culture, and identification of meningococci from clinical specimens. Methods in Molecular Medicine
2001; 67: 9–21.
Sobanski, MA, Barnes, RA, Coakley, WT. Detection of meningococcal antigen by latex agglutination. Methods in Molecular Medicine
2001; 67: 41–59.
Cunningham, SA, Mainella, JM, Patel, R. Misidentification of Neisseria polysaccharea as Neisseria meningitidis with the use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. Journal of Clinical Microbiology
2014; 52: 2270–2271.
Cartwright, KA, Stuart, JM, Robinson, PM. Meningococcal carriage in close contacts of cases. Epidemiology and Infection
1991; 106: 133–141.
Collard, JM, et al.
A five-year field assessment of rapid diagnostic tests for meningococcal meningitis in Niger by using the combination of conventional and real-time PCR assays as a gold standard. Transactions of the Royal Society of Tropical Medicine and Hygiene
2014; 108: 6–12.
Agnememel, A, et al.
Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis serogroup X. Journal of Clinical Microbiology
2015; 53: 449–454.
Chanteau, S, et al.
New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y. PLoS Medicine
2006; 3: e337.
Kaczmarski, EB, et al.
Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Communicable Diseases Public Health
1998; 1: 54–56.
Bryant, PA, et al.
Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. Journal of Clinical Microbiology
2004; 42: 2919–2925.
Bennett, DE, Cafferkey, MT. Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease. Journal of Clinical Microbiology
2006; 44: 1127–1131.
Dolan, Thomas J, et al.
sodC-based real-time PCR for detection of Neisseria meningitidis
. PLoS ONE
2011; 6: e19361.
Hedberg, ST, et al.
Real-time PCR detection of five prevalent bacteria causing acute meningitis. Acta Pathologica, Microbiologica, et Immunologica Scandinavica
2009; 117: 856–860.
Mölling, P, et al.
Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR. Journal of Clinical Microbiology
2002; 40: 4531–4535.
Taha, MK, et al.
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis
. Journal of Clinical Microbiology
2005; 43: 144–149.
Bratcher, HB, et al.
A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genomics
2014; 15: 1138.
Brehony, C, Jolley, KA, Maiden, MC. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiology Reviews
2007; 31: 15–26.
Fox, AJ, Taha, MK, Vogel, U. Standardized nonculture techniques recommended for European reference laboratories. FEMS Microbiology Reviews
2007; 31: 84–88.
Jolley, KA, Brehony, C, Maiden, MC. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiology Reviews
2007; 31: 89–96.
Lucidarme, J, et al.
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clinical and Vaccine Immunology
2010; 17: 919–929.
Jolley, KA, Maiden, MC. Automated extraction of typing information for bacterial pathogens from whole genome sequence data: Neisseria meningitidis as an exemplar. Eurosurveillance
2013; 18: 20379.
Vogel, U, et al.
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infectious Diseases
2013; 13: 416–425.
Donnelly, J, et al.
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proceedings of the National Academy of Sciences of the United States of America
2010; 107: 19490–19495.
Kelly, A, et al.
Gene variability and degree of expression of vaccine candidate factor H binding protein in clinical isolates of Neisseria meningitidis
. Acta Pathologica, Microbiologica, et Immunologica Scandinavica
2013; 121: 56–63.
Hong, E, et al.
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin. Antimicrobial Agents and Chemotherapy
2013; 57: 1961–1964.
Taha, MK, et al.
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis
. Antimicrobial Agents and Chemotherapy
2007; 51: 2784–2792.
Taha, MK, et al.
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrobial Agents and Chemotherapy
2010; 54: 3651–3658.
Gasparini, R, Panatto, D. Meningococcal glycoconjugate vaccines. Human Vaccines
2011; 7: 170–182.